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Open Access

Malaria research challenges in low prevalence
settings
Gillian Stresman1, Tamaki Kobayashi2, Aniset Kamanga3, Philip E Thuma4, Sungano Mharakurwa4,5,
William J Moss2 and Clive Shiff5*

Abstract
The prevalence of malaria has reduced significantly in some areas over the past decade. These reductions have
made local elimination possible and the research agenda has shifted to this new priority. However, there are critical
issues that arise when studying malaria in low transmission settings, particularly identifying asymptomatic infections,
accurate detection of individuals with microparasitaemic infections, and achieving a sufficient sample size to have
an adequately powered study. These challenges could adversely impact the study of malaria elimination if they
remain unanswered.

Background
After the failed eradication attempt of the 1950s, the malaria research objective was clear: reduce morbidity and
mortality rates in areas where malaria persisted. These
objectives made malaria relatively easy to study as areas
with high morbidity and mortality had a high prevalence
of infection as well as high parasite densities within
infected individuals [1-4]. The focus on mortality reduction led to the development and widespread use of important tools to fight malaria, such as insecticide-treated
bed nets, rapid diagnostic tests, and artemisinin, a drug effective against asexual parasitaemia and immature gametocytes, all of which have likely contributed to the
reductions in malaria transmission in some areas [5-7].
The dramatic decline in malaria transmission has led to a
shift from control to elimination as the primary goal [8].
This new malaria research agenda has led to new challenges: the populations of interest now include those that
experience a low prevalence of infection and consist of
asymptomatic and microparasitaemic individuals that may
be beyond the limit of detection with current diagnostic
tools. The ability to accurately study populations that are
likely responsible for sustaining malaria transmission from
one season to the next will be critical to achieving elimination, but are particularly difficult to assess with the diagnostic and epidemiological tools currently available [9,10].
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Therefore, it is essential to discuss the current methodological barriers to the study of malaria in settings of low
parasite prevalence and density, and the potential implications for confirming malaria elimination.

Targeting asymptomatic infections

In areas where malaria is sustained at low levels or is
highly seasonal, asymptomatic or minimally symptomatic
reservoirs of infection are critical for maintaining malaria
transmission as the parasite can persist in these individuals from one season to the next [11,12]. These reservoirs can comprise more than one third of a population
[13] and have inherent challenges that make them difficult
to identify, including the fact that these individuals do not
seek treatment [14]. However, locating asymptomatically
infected people and clearing this parasite reservoir will be
critical to sustainable local and national malaria elimination [15,16]. In addition to finding ways to detect and
prevent importation of malaria, as well as effective vector
control measures, if control programmes ignore the local
parasite reservoirs in human population’s malaria will
likely resurge once control efforts are scaled back. A strategy that is simple and cost-effective in targeting gametocyte reservoirs is needed that can easily be integrated into
local malaria control programmes.
Malaria infections tend to cluster in geographically
defined areas with a higher malaria transmission, or hotspots of infection, during the low transmission season.
These clusters that likely serve as the source of parasites
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that fuel subsequent transmission seasons [11]. The concept of hotspots could be used to target parasite reservoirs effectively and achieve maximum impact for
control programmes. For example, research conducted
in Zambia demonstrated that RDT-confirmed cases of
malaria presenting at health facilities during the low
transmission season could be used to target reservoirs of
asymptomatic infection [17]. However, this approach
may lead to sub-optimal coverage and may not be an efficient strategy in areas of low transmission intensity
[18]. Other possible methods to target reservoirs could
include using school surveys to identify possible hotspots of infection in the community or adults as a sentinel population [19]. If the defining characteristics of a
hotspot of malaria infection could be clearly identified
using either climate, entomological, or geographical data,
these indicators could serve as a powerful tool to inform
programmes on where to target control measures [20].
Detection of low levels of parasitaemia

Even with the existence of a valid method to easily detect
hotspots of malaria infection, including asymptomatic
populations, a second limitation is our ability to diagnose
infected individuals accurately. It is not uncommon for
individuals to be infected with parasites that are sustained
at microparasitaemic levels. The ability of current diagnostic tools to detect infections when parasite densities
are low is poor and individuals negative for malaria by
RDT or microscopy are still infectious to mosquitoes. [21]
The commonly used tools for malaria diagnosis for research purposes include microscopy, rapid diagnostic
tests, measuring the immune response to plasmodium
(serology), and various methods of DNA detection including polymerase chain reaction (PCR), loop-mediated isothermal amplification (LAMP), or nucleic acid sequencebased amplification (NASBA) [22]. Although microscopy
and RDT are the most commonly used methods of diagnosis, PCR can detect sub- patent infections and is frequently used for research purposes. [23,24]. However, the
validity of PCR has not been adequately assessed for
asymptomatic or microparasitaemic individuals: with a
negative PCR result, what is the probability that a person
is truly negative or is the negative due to insufficient sensitivity of the test? The analytical sensitivity of a nested PCR
is often cited as being able to detect as few as two parasites per milliliter of whole blood [25]. Although the lower
limit of detection is impressive, the consistency of the
results in microparasitaemic individuals has never been
properly assessed, especially in field settings where sample
collection and storage may not be optimum. Microparasitaemic individuals produce gametocytes and likely contribute to the infectious reservoir [14]. However,
individuals with infections below the sensitivity of PCR
have received little attention and the probability that these
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individuals will produce and transmit gametocytes to mosquitoes, as well as their contribution to the infectious reservoir, has not been addressed.
Power to detect the effectiveness of interventions

If it is possible to develop feasible strategies to target
asymptomatic populations, and methods exist that can
accurately identify those with low levels of parasitaemia,
a third challenge provides a more fundamental problem:
conducting valid epidemiological studies of malaria elimination in the field. The low transmission season is a
critical bottleneck for targeting malaria reservoirs that
sustain transmission from one season to the next, but
parasite prevalence during this period can be extremely
low. [11] Similarly, areas that have reduced transmission
can experience extremely low parasite prevalence
throughout the year. Both of these circumstances render
these regions ideal for elimination campaigns. However,
when any disease is uncommon, irrespective of the study
design used, epidemiological studies become difficult because of challenges in reaching the desired sample size
to achieve adequate power to minimize the probability
of wrongly accepting that the null hypothesis is true,
known as type II error. For example, a recent clusterrandomized trial carried out in Tanzania to determine
the effect of mass drug administration on malaria transmission failed to detect a significant effect between the
intervention and control arms because the incidence of
malaria was low in the control arm [26].
Achieving the desired sample size and adequate study
power is essential for conducting conclusive studies. For
some surveys, the challenge of sample size could be overcome by increasing the number of people, increasing the
duration of sample collection or survey a broader geographical area. These alternatives come with additional
costs and possible challenges of changes in seasonality or
variation in the micro epidemiology having an impact on
the desired outcome [27,28]. Other options include alternative study designs. For example, the use of a pre/post
design or the absence of a control population are not
common in malaria epidemiology research because traditional epidemiological practice requires a design that
allows the relative impact to be measured in reference to a
comparison group. However, if malaria is eliminated in a
population and the absence of infection confirmed by the
absence of malaria antibodies circulating in the blood or
other definitive test such as a PCR assay that is both sensitive and demonstrates consistent results, then the effectiveness of the approach would have been demonstrated.
The ability to study malaria with sufficient power in elimination settings will be critical to provide insight to the
best approaches, their effectiveness and to identify the significance of importations of parasites using molecular
epidemiology.
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Implications for malaria elimination

The presence of asymptomatic infections, the inability
to accurately diagnose microparasitaemic infections
and gametocytemia, and the difficulty in achieving adequately powered studies in the context of low malaria
prevalence all have serious implications for malaria
elimination campaigns. How is it possible to understand malaria in low prevalence settings if there is little confidence that the people reported to be negative
by PCR are uninfected? If sufficiently powered studies
are difficult or impossible to implement, is it possible
to eliminate the probability of a null hypothesis? The
World Health Organization (WHO) defines malaria as
eliminated in an area if there is zero incidence of locally acquired clinical cases in a defined geographical
area during three consecutive years [29]. In settings
with large numbers of asymptomatically infected
people, how can this be assessed without testing populations for serological evidence of recent exposure?
Until sufficient measures for elimination are developed
for use in areas with persistent pockets of asymptomatic or minimally symptomatically infected individuals,
or a successful mass drug administration campaign or
vaccine is implemented, how is it possible to claim
that these malaria reservoirs are truly eliminated? Also,
how perfect does the optimum diagnostic method
need to be before there is confidence in the results in
an elimination context? In other words, what is the
implication for continued transmission if even just one
person is misclassified as negative who is actually carrying parasites? For malaria elimination to be sustainable and stand a real chance for success, it is
imperative that these fundamental questions in studying malaria in low prevalence settings are addressed
while it is still possible for malaria elimination campaigns to succeed.
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